Immunopharmacology

Effect of phosphodiesterase inhibition on IL-4 and IL-5 production of the murine T_H2-type T cell clone D10.G4.1
pp. 191-198(8)
Authors: Schmidt J.; Hatzelmann A.; Fleiszner S.; Heimann-Weitschat I.; Lindstaedt R.; Szelenyi I.

Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation
pp. 199-207(9)
Authors: Ryffel B.; Willcocks J.L.; Brooks N.; Woerly G.

Dissociation between the mitogenic effect and antitumor activity of seed extract from Aeginetia indica L.
pp. 209-215(7)
Authors: Chai J.-G.; Okamoto M.; Bando T.; Nagasawa H.; Hisaeda H.; Sakai T.; Himeno K.; Sato M.; Ohkubo S.

Enhancement of phagocytosis in mouse macrophages by pituitary adenylate cyclase activating polypeptide (PACAP) and related peptides
pp. 217-224(8)
Authors: Ichinose M.; Asai M.; Imai K.; Sawada M.

The effect of chronic treatment with imipramine on the immunoreactivity of animals subjected to a chronic mild stress model of depression
pp. 225-230(6)
Authors: Kubera M.; Basta-Kaim A.; Papp M.

Modulatory effect of plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) on macrophage functions in BALB/c mice. I. Potentiation of macrophage bactericidal activity
pp. 231-236(6)
Authors: Abdul K.M.; Ramchender R.P.

Pharmacodynamics of prophylactic antirejection therapy with an anti interleukin-2 receptor monoclonal antibody (BT563) after heart and kidney transplantation
pp. 237-246(10)
Authors: Hesse C.J.; van Gelder T.; Vaessen L.M.B.; Knoop C.J.; Balk A.H.M.M.; Yzermans J.N.M.; Jutte N.H.P.M.; Weimar W.

Effects of isoniazid treatment on human lymphocyte proliferative response, lymphocyte subsets and natural killer cell activity
pp. 247-253(7)
Authors: Ravn P.; Linnet J.; Klokker M.; Pedersen B.K.